Binding of human syndecan to extracellular matrix proteins.

Binding of human syndecan to extracellular matrix proteins.

We have isolated a cell surface proteoglycan from a human mammary cell line (HBL-100). This proteoglycan was found to be a human equivalent to mouse syndecan, because (i) it has identical biochemical properties with murine syndecan, including size, charge, buoyant density, and glycosaminoglycan comp...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Klaus Elenius, Markku Salmivirta, Pirjo Inki, Markku Mali, Markku Jalkanen
Format:	Artigo
Jezik:	angleščina
Izdano:	1990
Online dostop:	https://doi.org/10.1016/s0021-9258(18)38239-5
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Growth factors induce 3T3 cells to express bFGF-binding syndecan.
od: Klaus Elenius, et al.
Izdano: (1992)

Induced expression of syndecan in healing wounds.
od: Klaus Elenius, et al.
Izdano: (1991)

Syndecan from embryonic tooth mesenchyme binds tenascin.
od: Markku Salmivirta, et al.
Izdano: (1991)

Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth.
od: Markku Salmivirta, et al.
Izdano: (1992)

Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1.
od: Markku Mali, et al.
Izdano: (1993)

Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck
od: Pirjo Inki, et al.
Izdano: (1994)

Suppression of tumor cell growth by syndecan-1 ectodomain.
od: Markku Mali, et al.
Izdano: (1994)

Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans.
od: Markku Mali, et al.
Izdano: (1990)

Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells.
od: Sirpa Leppä, et al.
Izdano: (1992)

Binding of Heparin/Heparan Sulfate to Fibroblast Growth Factor Receptor 4
od: Britt-Marie Loo, et al.
Izdano: (2001)

Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme.
od: Seppo Vainio, et al.
Izdano: (1989)

Molecular cloning of syndecan, an integral membrane proteoglycan.
od: Scott Saunders, et al.
Izdano: (1989)

Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.
od: Sirpa Leppä, et al.
Izdano: (1991)

Syndecan-1 expression has prognostic significance in head and neck carcinoma
od: Anu Anttonen, et al.
Izdano: (1999)

Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor
od: Määttä, Jorma A, et al.
Izdano: (2009)

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
od: S Jalkanen, et al.
Izdano: (1992)

Expression of proteoglycans and hyaluronan during wound healing.
od: Olli Oksala, et al.
Izdano: (1995)

Inhibition by the Soluble Syndecan-1 Ectodomains Delays Wound Repair in Mice Overexpressing Syndecan-1
od: Varpu Elenius, et al.
Izdano: (2004)

Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization
od: Jaana Korhonen, et al.
Izdano: (1992)

Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation.
od: Inki, P., et al.
Izdano: (1991)

Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain.
od: Markku Jalkanen, et al.
Izdano: (1987)

Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.
od: Inki, P., et al.
Izdano: (1994)

Characterization of Heparin and Heparan Sulfate Domains Binding to the Long Splice Variant of Platelet-derived Growth Factor A Chain
od: Emadoldin Feyzi, et al.
Izdano: (1997)

Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man.
od: Sirpa Jalkanen, et al.
Izdano: (1988)

Emerging Role of Syndecans in Extracellular Matrix Remodeling in Cancer
od: Jang, Bohee, et al.
Izdano: (2020)

Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells.
od: Leppä, S, et al.
Izdano: (1992)

Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
od: Hannu Järveläinen, et al.
Izdano: (2009)

Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
od: Järveläinen, Hannu, et al.
Izdano: (2009)

Age-dependent Modulation of Heparan Sulfate Structure and Function
od: Emadoldin Feyzi, et al.
Izdano: (1998)

Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.
od: Markku Jalkanen, et al.
Izdano: (1988)

HUMAN GRANULOSA CELLS SYNTHESIZE LOW MOLECULAR WEIGHT INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN
od: Anne‐Maria Suikkari, et al.
Izdano: (1989)

Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2
od: Johan Kreuger, et al.
Izdano: (2001)

Fibroblast growth factors share binding sites in heparan sulphate
od: Johan Kreuger, et al.
Izdano: (2005)

Fibroblast growth factors share binding sites in heparan sulphate
od: Kreuger, Johan, et al.
Izdano: (2005)

The Tiam1 PDZ Domain Couples to Syndecan1 and Promotes Cell-Matrix Adhesion
od: Shepherd, Tyson R., et al.
Izdano: (2010)

Synthesis and localization of two sulphated glycoproteins associated with basement membranes and the extracellular matrix.
od: Brigid L.M. Hogan, et al.
Izdano: (1982)

Novel Heparan Sulfate Structures Revealed by Monoclonal Antibodies
od: Jacob van den Born, et al.
Izdano: (2005)

Isolation of the pericellular matrix of human fibroblast cultures.
od: Klaus Hedman, et al.
Izdano: (1979)

Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
od: Takako Sasaki, et al.
Izdano: (1999)

Involvement of protein kinase A in fibroblast growth factor-2-activated transcription
od: Pursiheimo, Juha-Pekka, et al.
Izdano: (2000)